AstraZeneca PLC (NYSE: AZN) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Andy Barnett -- Head of Investor Relations Pascal Soriot -- Executive Director
Categories
Health Care
EssilorLuxottica (EL) Q2 2022 Earnings Call Transcript
EssilorLuxottica (PA: EL) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Francesco Milleri -- Chairman and Chief Executive Officer Paul du Saillant -- Deputy
ABBV Earnings: Highlights of AbbVie’s Q2 2022 financial results
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) has reported double-digit growth in second-quarter adjusted earnings, reflecting an increase in revenues. The company also
Pfizer Inc. (PFE) Q2 2022 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q2 2022 earnings call dated Jul. 28, 2022 Corporate Participants: Christopher Stevo -- Senior Vice President and Chief Investor Relations
Tilray, Inc. (TLRY) Q4 2022 Earnings Call Transcript
Tilray, Inc. (NASDAQ: TLRY) Q4 2022 earnings conference call dated Jul. 28, 2022 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin David
Bristol Myers Squibb (BMY) Q2 2022 Earnings: Key financials and quarterly highlights
Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today. Total revenue grew 2% year-over-year to $11.9 billion. Net earnings
Pfizer (PFE) Q2 2022 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported second quarter 2022 earnings results today. Total revenues increased 47% year-over-year to $27.7 billion. Reported net income
Humana Inc. (HUM) Q2 2022 Earnings Call Transcript
Humana Inc. (NYSE: HUM) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lisa Stoner -- Vice President, Investor Relations Bruce D. Broussard -- President
Boston Scientific Corp (BSX) Q2 2022 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lauren Tengler -- Director of Investor Relations Michael F.
MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues. The top
Petmed Express Inc. (PETS) Q1 2023 Earnings Call Transcript
Petmed Express Inc. (NASDAQ: PETS) Q1 2023 earnings call dated Jul. 25, 2022 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer
TRxADE HEALTH, Inc. (MEDS) Q2 2022 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 earnings call dated Jul. 25, 2022 Corporate Participants: Janet Huffman -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Intuitive Surgical, Inc. (ISRG) Q2 2022 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Brian King -- Treasurer and Head of Investor Relations
Intuitive Surgical Inc. (ISRG) Earnings: 2Q22 Key Numbers
Intuitive Surgical Inc. (NASDAQ: ISRG) reported revenue of $1.52 billion for the second quarter of 2022, up 4% year-over-year. GAAP net income
IQVIA Holdings Inc. (IQV) Q2 2022 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE: IQV) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Nick Childs -- Senior Vice President, Investor Relations and
Quest Diagnostics Inc. (DGX) Q2 2022 Earnings Call Transcript
Quest Diagnostics Inc. (NYSE: DGX) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen
Abbott (ABT) Q2 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions Robert
Biogen Inc. (BIIB) Q2 2022 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Michael Hencke -- Head of Investor Relations. Michel Vounatsos -- Chief Executive
Anthem, Inc. (ANTM) Q2 2022 Earnings Call Transcript
Anthem, Inc. (NYSE: ANTM) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Stephen Tanal -- Vice President, Investor Relations Gail K. Boudreaux -- President
Johnson & Johnson (JNJ) Q2 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joaquin Duato -- Chief
Novartis AG (NVS) Q2 2022 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant (Vas)